037. HIV on the Horizon
Thursday, October 5, 2017: 10:30 AM-12:00 PM
Room: 11AB

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • discuss the state of HIV cure research and potential clinical implications
  • describe the role of broadly neutralizing antibodies for treatment and prevention of HIV infection
  • explain the management of inflammation in patients with HIV

Target Audience: Academicians, Clinicians, Fellows, HIV clinicians, HIV specialists, Infectious diseases physicians, Investigators, Members-in-training, Nurses, Pharmacists, Public health practitioners, Researchers, Scientists, Vaccinologists

Tracks: Pediatric ID, HIV-STD-TB, Adult ID

Moderators:  Rajesh Gandhi, MD, FIDSA, Massachusetts General Hospital and Eileen Scully, MD, PhD, Johns Hopkins School of Medicine

10:30 AM
HIV Cure Research Update
Daniel Kuritzkes, MD, FIDSA

11:45 AM

CME Credits: Maximum of 1.50 hours of AMA PRA Category 1 Credit™

ACPE Credits: ACPE 1.5 knowledge-based contact hours of pharmacy CE

ACPE Number: 0221-9999-17-245-L02-P


R. Gandhi, Gilead: Educational grant to MGH , Educational grant
Merck: Educational grant to MGH , Educational grant
Viiv: Educational grant to MGH , Educational grant
Theratechnologies: Scientific Advisor , Consulting fee
EMD Serono: Consultant , Consulting fee

E. Scully, None

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 4th with the exception of research findings presented at the IDWeek press conferences.